Princeton Junction, NJ, United States of America

Galla Chandra Rao

This inventor holds 21 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Circulating Tumor Cell Analysis. Top assignees: Immunivest Corporation, Veridex, Lcc, Menarini Silicon Biosystems, Inc.. Active years: 1997-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Galla Chandra Rao. Retrieved from https://idiyas.com/inventor/galla-chandra-rao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 5)

% Patents Active = 90.5

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 9)

Average Co-Inventor Count = 3.7

ph-index = 16

Forward Citations = 1,903(Granted Patents)

Location History:

Princeton, NJ (US) (1997 - 2010)
Princeton Jct., NJ (US) (2003 - 2017)
Princeton Junction, NJ (US) (2011 - 2023)

Company Filing History:

11 out of 35

Immunivest Corporation

Menarini Silicon Biosystems, Inc.

Janssen Diagnostics, LLC

patents

6. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2023

Loading Chart...

Areas of Expertise:

Circulating Tumor Cells

Molecular Characterization

Optical Analysis

Cancer Cell Isolation

Magnetic Nanoparticles

Particulate Entities

Disease State Assessment

Functional Controls

Binding Interactions

Separation Efficiency

Specimen Sample Cartridge

Magnetically Responsive Particles

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11567081 - Method of isolating circulating tumor cells (2023-01-31),

2. 10365266 - Molecular characterization of circulating tumor cells (2019-07-30),

3. 10161939 - Method of isolating circulating tumor cells (2018-12-25),

4. 9823238 - Molecular characterization of circulating tumor cells (2017-11-21),

5. 9618515 - Assay to capture and detect circulating multiple myeloma cells from blood (2017-04-11),

6. 8329422 - Analysis of circulating tumor cells, fragments, and debris (2012-12-11),

7. 7901950 - Method for assessing disease states by profile analysis of isolated circulating endothelial cells (2011-03-08),

8. 7863012 - Analysis of circulating tumor cells, fragments, and debris (2011-01-04),

9. 7815863 - Cartridge for containing a specimen sample for optical analysis (2010-10-19),

10. 7332288 - Methods and reagents for the rapid and efficient isolation of circulating cancer cells (2008-02-19),

11. 7282350 - Labeled cell sets for use as functional controls in rare cell detection assays (2007-10-16),

12. 7011794 - Upon a cartridge for containing a specimen sample for optical analysis (2006-03-14),

13. 6645731 - Methods and reagents for the rapid and efficient isolation of circulating cancer cells (2003-11-11),

14. 6623983 - Apparatus and methods for capture and analysis of particulate entities (2003-09-23),

15. 6620627 - Increased separation efficiency via controlled aggregation of magnetic nanoparticles (2003-09-16),

Title: Galla Chandra Rao: Advancements in Tumor Cell Isolation

Introduction

Galla Chandra Rao, based in Princeton Junction, NJ, is an accomplished inventor known for his influential contributions to the field of cancer research. With a remarkable portfolio of 21 patents, Rao has dedicated his career to developing innovative methods for the detection and isolation of circulating tumor cells (CTCs), which are crucial for cancer diagnosis and treatment.

Latest Patents

One of Galla Chandra Rao's significant patents is a method of isolating circulating tumor cells. This invention provides methods for detecting or isolating CTCs in a subject, incorporating the detection of at least one epithelial-mesenchymal transition (EMT) biomarker. The invention also includes kits designed for the detection or isolation of CTCs, containing antibodies against EMT biomarkers. Furthermore, the patent entails methods for predicting a subject's responsiveness to cancer drugs, targeting drug delivery, providing cancer prognosis, and monitoring cancer progress.

Another notable patent by Rao involves the molecular characterization of circulating tumor cells. This innovation outlines methods and kits for removing white blood cells from samples of immunomagnetically enriched rare cells. The technique utilizes a leukocyte marker conjugated to a hapten that adheres to the white blood cells, allowing for the effective removal of these cells from the sample.

Career Highlights

Galla Chandra Rao's career is marked by his work at esteemed organizations, including Immunivest Corporation and Veridex, LLC. His engagements in these companies have significantly contributed to advancements in cancer diagnostics and therapeutics. Rao’s commitment to innovation in the medical field has established him as a leading figure in the application of patent-protected techniques for cancer treatment.

Collaborations

Throughout his career, Galla Chandra Rao has collaborated with professionals like Paul A. Liberti and Leon W. M. Terstappen. These collaborations have fostered an environment of innovation, enabling breakthroughs that advance cancer research and improve patient outcomes through better detection and treatment methods.

Conclusion

Galla Chandra Rao's contributions to the field of circulating tumor cell research highlight the intersection of innovation and healthcare. His numerous patents not only demonstrate his inventive prowess but also signify the potential to enhance cancer diagnosis and treatment methodologies. As such, Rao continues to pave the way for future advancements in cancer research, demonstrating a profound impact on the medical community.

Profile summary based on public USPTO records.